The Flow Cytometry Market is expected to grow from USD 4.24 billion in 2019 to USD 7.65 billion by 2026 at a CAGR of 8.79% from 2020 to 2026.
Flow Cytometry is a laser or impedance-based biophysical technology that is used for cell sorting & counting and detecting biomarkers in protein engineering. This allows analysis of the physical and chemical characteristics of thousands of particles. The major uses of flow cytometry are in the diagnosis of health disorders, like blood cancers. Some other applications of the flow cytometry contain research, experimental practice, and clinical trials. Technological developments in flow cytometers, increasing acceptance of these techniques in research activities & clinical trials, and the rising frequency of chronic diseases are the major drivers that are likely to antedate the development of the market. Growth in stem cell research and the development of high-throughput flow cytometry technologies are likely to add new opportunities for this market in the coming years. A considerable increase in the adoption of these techniques in the clinical trials and research activities is expected to encourage the growth of the global market in the next few years. The global market is segregated on the basis of Application as Industrial Applications, Clinical Applications, and Research Applications. Based on End User the global market is segmented in Hospitals & Clinical Testing Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. Based on Product and Service the global market is segmented in Services, Software, Accessories, Reagents and Consumables, and Instruments. Based on Technology, the global market is segmented in Bead-based Flow Cytometry and Cell-based Flow Cytometry.
The global Flow Cytometry market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Biomérieux SA, Cytonome/St, LLC, Stratedigm, Inc, Apogee Flow Systems, Cytek Biosciences, Inc, Becton, Dickinson, and Company, Beckman Coulter, Thermo Fisher Scientific, Merck KGaA, Luminex Corporation, and others are among the major players in the global market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Flow Cytometry market has been segmented as below:
By Application
By End-User
By Product and Service
By Technology
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global Flow Cytometry market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the global market share. Major industry players with significant revenue share include Biomérieux SA, Cytonome/St, LLC, Stratedigm, Inc, Apogee Flow Systems, Cytek Biosciences, Inc, Becton, Dickinson and Company, Beckman Coulter, Thermo Fisher Scientific, Merck KGaA, Luminex Corporation, and others.
Why to Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Industrial Applications
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Clinical Applications
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Research Applications
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6.1 Introduction
6.2 Hospitals & Clinical Testing Laboratories
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Pharmaceutical & Biotechnology Companies
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Academic & Research Institutes
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7.1 Introduction
7.2 Services
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Software
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Accessories
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Reagents and Consumables
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Instruments
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8.1 Introduction
8.2 Bead-based Flow Cytometry
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Cell-based Flow Cytometry
8.3.1 Market Overview
8.3.2 Market Size and Forecast
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Application
9.2.2 Europe Market, By End User
9.2.3 Europe Market, By Product and Service
9.2.4 Europe Market, By Technology
9.3 North America
9.3.1 North America Market, By Application
9.3.2 North America Market, By End User
9.3.3 North America Market, By Product and Service
9.3.4 North America Market, By Technology
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Application
9.4.2 Asia Pacific Market, By End User
9.4.3 Asia Pacific Market, By Product and Service
9.4.4 Asia Pacific Market, By Technology
9.5 Rest of The World
9.5.1 Rest of The World Market, By Application
9.5.2 Rest of The World Market, By End User
9.5.3 Rest of The World Market, By Product and Service
9.5.4 Rest of The World Market, By Technology
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11.1 Biomérieux SA
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Cytonome/St, LLC
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Stratedigm, Inc
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Apogee Flow Systems
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Cytek Biosciences, Inc
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Becton, Dickinson and Company
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Beckman Coulter
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
&a